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Abstract
Tissue harmonic imaging (THI) is highly effective for correct diagnosis. On the other
hand, pulse compression is often used in a radar system and an ultrasound imaging
system to perform high SNR measurement. Therefore, the performance of pulse compres-
sion of tissue harmonic imaging is required to be improved. The frequency-dependent
attenuation (FDA) is a crucial problem in medical tissue imaging. In the pulse compres-
sion imaging, the deterioration of echoes by the FDA lowers the performance of a matched
filtering using an ideal transmitted pulse as a template signal. Since, especially in the
harmonic imaging, higher-frequency components are used for imaging than the funda-
mental imaging, the compensation of the FDA is strongly important for high-definition
imaging. In this study, we examine a method to reduce the influence of the FDA on
harmonics.
Keywords: FDA, pulse compression, tissue harmonic imaging, FM chirp, compensation
for FDA
1. Introduction
The ultimate goal of our study is to perform high-resolution and high signal-to-noise ratio
(SNR) ultrasound imaging required for high-quality diagnosis. Such imaging is strongly
demanded particularly in the deep part of a living body. On the other hand, we are developing
a puncture ultrasound microscope [1–3], in which echo is very weak and cell-level resolution is
required, so high-definite imaging technique is absolutely important. A pulse compression
technique (PCT) is effective for improving SNR while maintaining safety to the living body
[4–6].
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
In PCTs, broadband modulation is necessary to improve the range resolution. The bandwidth
that is used efficiently for transmission and reception is limited by the resonance characteristics
of the transducer that utilizes thickness resonance vibration. In order to widen the bandwidth
of the transducer, a layered-type transducer has been developed in which two piezoelectric
oscillators having different thicknesses are longitudinally bonded and one of a pair of elec-
trodes is inserted between two oscillators [7]. In addition, we are proposing the concept of a
new transducer based on a PMUT structure with a thicker diaphragm than conventional
PMUT and by which the bandwidth can be greatly widened [8]. In general, the wide band-
width of the transmitted pulses is a prerequisite for sharp pulses. Therefore, broadband
transmission in PCTs improves range resolution. On the other hand, in order to improve the
SNR by PCTs, it is necessary to increase energy inflow into the body by transmitting a signal
with a wide pulse width. Namely, a PCT using pulses having a wideband and a wide pulse
width is suitable for our objective.
Due to its high resolution, tissue harmonic imaging (THI) is useful, and many studies have been
done [9, 10]. THI uses harmonic components generated as nonlinear distortion caused by ultra-
sonic propagation in living tissue for imaging. In a commercial implement, the second harmonic
component is generally used since its amplitude is drastically greater than the amplitude of the
higher-order harmonic components. The advantages of THI can be summarized as follows: (i)
THI has high-resolution characteristics along the range direction compared to fundamental
imaging due to the broadband characteristics of the harmonic components, (ii) THI has high-
resolution characteristics along the azimuth direction since the nonlinear effect strongly occurs at
the center of the transmitted beam with high sound pressure, and (iii) there are almost no
artifacts such as multiple reflection and side lobes in THI since the sound pressure of the echo
reflected from the scatterer is low and hence the sound pressure of the multiple reflected echo is
further low, and the amplitude of the side lobes of harmonics is 60–80 dB smaller than that of the
main lobe. On the other hand, in THI the amplitude of the harmonic components is significantly
smaller than the amplitude of the fundamental component. In order to solve this problem, we
proposed a method based on the Bayesian estimation using the prior information of the second
harmonic echoes introduced from fundamental echoes [11].
Applying a PCT to THI is expected to improve the SNR while maintaining high-resolution
characteristics, but frequency-dependent attenuation (FDA) must be strongly aware. FDA
causes severe distortion of echo signals, when the broadband pulse propagates through the
soft tissue in the living body. Since the high-frequency component attenuates more than the low-
frequency component, particularly large distortion occurs in harmonic components. Figure 1
shows the FDA in the time domain and Figure 2 shows it in the frequency domain. The
distortion of the echo caused by FDA makes exact pulse compression impossible, and, hence,
image blurring occurs [10]. In order to prevent the SNR degradation and of the range resolution
degradation due to the echo distortion caused by FDA, we have proposed an FDA compensation
method [12–14]. In the methods, an amplitude-modulated FM chirp pulse is transmitted, the
echo for which is distorted by FDA and, as a result, is received as an ideal waveform. The proper
amplitude modification (AM) of the transmission is determined using the FDA characteristic
measured by transmitting a reference pulse toward a region of interest (ROI) and receiving the
corresponding echo. Since the methods proposed [12, 13] have been constructed for fundamental
imaging, this study aims to extend them for THI imaging. The method [13] was constructed for
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harmonic imaging, but the compensation of the transducer characteristics was insufficient,
which will be solved in this study to propose an FDA compensation method with high com-
pleteness. Typical purposes of AM of an FM chirp signal are side-lobe suppression and compen-
sation of the resonance characteristics of a transducer [15]. The techniques for these purposes can
be also integrated into our method. The effectiveness of our method on the harmonic FDA
compensation is confirmed through numerical simulations by finite element method (FEM) and
simple experiments.
2. Method
2.1. Transducer characteristic compensation
2.1.1. Compensation for fundamental band
Before considering FDA compensation, it is necessary to correct the frequency characteristic of
the transducer, which must be done only once for each transducer. For fundamental imaging,
the transmission and reception characteristics of the transducer are simply compensated for
Figure 1. Temporal distortion caused by FDA: (a) transmitted signal, (b) fundamental echo, and (c) second harmonic
echo.
Figure 2. FDA represented in frequency domain: (a) without FDA and (b) after FDA distortion. Green boxes indicate
fundamental band and second harmonic band.
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both amplitude and phase. To evaluate the characteristic, any arbitrary FM chirp signal f(t)
covering the entire frequency band used for imaging is applied as a voltage to the transducer,
and the corresponding echo g(t) is received. Their frequency representations are denoted as
F(ω) and G(ω), respectively. The complex distortion function R(ω) is defined as follows:
R wð Þ ¼
H wð Þ
G wð Þ
: (1)
In this equation, H(ω) is the frequency representation of the ideal FM chirp signal and should
have spectrum amplitude with a window function suitable for reducing side lobes.
S(ω) defined by the following equation can be adopted as a transmission pulse for compensat-
ing transducer characteristics and observing an appropriate FM chirp echo:
S wð Þ ¼ R wð ÞF wð Þ: (2)
The simulation confirmed that beam focusing has little effect on measuring transducer charac-
teristics.
2.1.2. Compensation for fundamental transmission and harmonic reception
For tissue harmonic imaging, the transmission characteristic in the fundamental frequency
band and the reception characteristic in the harmonic frequency band must be corrected at
the same time. That is, the harmonic echo is distorted due to the fundamental transmission
characteristic and the harmonic reception characteristic. Hereafter, attention is focused only on
the second harmonic component. The fundamental transmission characteristic can be evalu-
ated by experimentally measuring the transmitted pressure by a hydrophone. We represent an
arbitral FM chirp transmission signal fF(t) and the corresponding pressure gF(t) measured in
the propagation medium and define the fundamental transmission distortion as RF(ω) =HF(ω)/
GF(ω), where HF(ω) is a frequency representation of an ideal fundamental FM chirp signal. The
harmonic reception distortion is defined as RH(ω) = HH(ω)/GH(ω), where HH(ω) is a frequency
representation of an ideal second harmonic FM chirp signal. The harmonic reception charac-
teristic can be evaluated by measuring the transmitted pressure fH(t) and the received echo
voltage gH(t) in the transmission/reception experiment using the frequency band corres-
ponding to the second harmonic frequency under the condition that FDA can be neglected.
Furthermore, the mapping from the fundamental component CF(ω) to the second harmonic
component CH(ω) in the frequency domain is defined as follows:
CH wð Þ ¼ Mconv CF wð Þð Þ: (3)
In addition, the inverse mapping is also defined as follows:
CF wð Þ ¼ Minv CH wð Þð Þ: (4)
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These mapping functions can simply be determined by scaling and shifting the corresponding
components on the frequency axis. The scale factor between CF(ω) and CH(ω) is not important,
as it is only intended to reduce the distortion of the spectral shape.
Using these definition and the harmonic pressure fH(t) generated in the tissue and returned to
the transducer, the transmission signal that compensates for the transducer characteristic
signal SH(ω) can be generated as follows:
SH wð Þ ¼ RF wð ÞMinv RH wð ÞFH wð Þð Þ: (5)
As the transmitted fundamental pulse propagates toward the ROI, harmonics are gradually
generated, and such a detailed process is ignored in the derivation of the above equation. To
generate the time signal sH(t) corresponding to SH(ω), it is necessary to perform somewhat
complicated experiments. Instead of the experiments, it is realistic to calculate transducer
characteristics by simulating exactly the material and structure of the transducer. In this
study, we determine the distortion functions RF(ω) and RH(ω) by simulations. Details of the
simulation procedure are described in Section 3. Figure 3 shows the results of the transducer
Figure 3. Simulation results of transducer characteristic compensation. Ideal FM chirp signal shown in (a) is applied to
transducer, and second harmonic echo in (b) is received without attenuation in water. Signal that compensates for
transducer characteristic which is determined by Eq. (5) is shown in (c), and corresponding second harmonic echo is
shown in (d).
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characteristic compensation. By comparing Figure 3(b) and (d), it can be confirmed that the
transducer characteristics are almost corrected.
2.2. FDA compensation
2.2.1. Method for fundamental component
FDA compensation can be performed basically in the same way as compensating the characteris-
tics of the transducer. However, it is noted that the FDA compensation should be carried out for
each region of interest (ROI) that is required to be finely imaged. To estimate the distortion
characteristics caused by FDA in the propagation medium, as a reference transmission for investi-
gation, we transmit sF(t) defined by Eq. (2) representing a frequency representation, which already
compensates for the characteristics of the transducer in the fundamental band, with focusing on
the ROI, and we receive the echo signal eF(t) as voltage. In this study, we assume that the FDA
affects the amplitude of the echo signal and that the phase is unaffected. Therefore, the fundamen-
tal distortion function of the FDA for the fundamental component RFFDA(ω) is defined as.
RFFDA wð Þ ¼
HF wð Þ
EF wð Þ
: (6)
By using this, the transmission signal SFcmp(ω) suitable for compensating the FDA in the
fundamental band can be determined as follows:
SFcmp wð Þ ¼ RFFDAj jSF wð Þ: (7)
The definition of RFFDA(ω) in Eq. (6) is an ideal formation, and its actual estimate is described
in Section 3.4. Therefore, in our previous study [12], the generation of SFcmp(ω) is iteratively
done, but we confirmed that the FDA can be compensated almost at once [13]. In the following
simulations and experiments, the compensation is done with only one reference transmission/
reception.
2.2.2. Method for harmonic component
We transmit sH(t) corresponding to Eq. (5) and receive the corresponding second harmonic
echo eH(t); the second harmonic distortion function of FDA is defined in the same way as in
Eq. (6):
RHFDA wð Þ ¼
HH wð Þ
EH wð Þ
: (8)
Therefore, the transmission signal SHcmp(ω) that compensates for the FDA in the second
harmonic band can be determined as follows:
SHcmp wð Þ ¼ RFFDA wð Þj jMinv RHFDA wð Þj jMconv SH wð Þð Þð Þ: (9)
It should be noted that the FDA within the fundamental band only occurs in the outbound
path from the transducer to the reflective target. However, since the scale factor as a constant
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independent of the frequency does not affect the distortion of the waveform, |RFFDA(ω) can be
used in Eq. (10) without reducing it to half.
The amplitude-modulated FM chirp pulse sHcmp(t) corresponding to sHcmp(ω) is transmitted,
and then its echo that is expected to have no FDA distortion is used for imaging. Instead of the
proposed modification of the transmission pulse, you can amplify the echo and easily reduce
the FDA distortion. However, in this case, the SNR is drastically lowered particularly at the
high-frequency portion, and the imaging quality is lowered.
3. Simulations
3.1. Simulation condition for transducer characteristic compensation
The simulations in this study were performed using PZFlex (Weidlinger Associates, Inc.), which
is a standard finite element method (FEM) simulator for ultrasound propagation and piezoelec-
tric analysis. A two-dimensional simulation model for determining a transmission signal that
compensates transducer characteristics is shown in Figure 4. A linear array transducer having 64
oscillating elements of PZTwas assumed, and an iron plate was used as a reflector. Parameters of
the transmission signal is shown in Table 1. To evaluate the characteristics of the transducer
purely, FDA should not occur, so the attenuation coefficient of water is set to 0 dB/cm/MHz. The
transmission pulse is focused on the front face of the iron plate. The characteristics of the
transducer and the signal compensating for it can be confirmed from the simulation results
already shown in Figure 3 in Section 2.1.2.
3.2. Definition of FDA model
In the PZFlex, the definition of FDA is represented as
FDA ¼ d f c=f d
 n dB
cm
 
, (10)
where d is the in vivo attenuation coefficient, fc is the center frequency, fd is the measurement
frequency, and n is the exponent of FDA. Through the simulations assuming tissue with FDA
modeled by logarithmic linear characteristic, namely, n = 1, we confirmed that this model is
effective [12]. However, a living body generally has logarithmic nonlinear characteristics.
Therefore, we experimentally measured the value of n for a phantom mimicking living tissue,
and as a result, n = 1.6 was obtained, and this value is used in the following simulations.
3.3. Simulation condition for FDA compensation
It is necessary to confirm the effectiveness of our method under medical usage condition
assuming a living body. Since it is difficult to verify such effectiveness from the beginning
through experiments, two-dimensional FEM simulations were performed using a model
shown in Figure 5 in which the propagation medium imitates the liver and the object corre-
sponds to a tumor. Transmission pulses are formed in the same way as the simulations in
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Figure 4. Simulation model for compensating transducer characteristics.
Figure 5. Simulation model for FDA compensation.
Type of transmission signal FM chirp with Hanning window
Center frequency [MHz] 10
Frequency bandwidth [MHz] 4
Pulse duration [μm] 5
Focus of transducer [mm] 15
Sampling frequency [MHz] 500
Transmission voltage [V] 40
Number of oscillator elements 64
Table 1. Measurement condition in simulations.
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Section 3.1 and are focused on 30 mm away from the transducer, i.e., on the front of the target
object. Parameters of the transmission signal are also the same as in Table 1 in Section 3.1. The
medium in Figure 5 consists of scatterers that can mimic the speckle patterns of the liver.
Sound speed, density, and attenuation coefficient of each scatterer are randomly defined
within the range of Table 2. The blue object shown in Figure 5 mimics the tumor, and its
properties are also shown in Table 2. We simulate the echoes reflected from the front of the
object and analyze them.
3.4. Results of harmonic FDA compensation
The absolute values of RFFDA in Eq. (6) and RHFDA in Eq. (8) must be estimated from the reference
echo received by transmitting the FM chirp pulse in Eq. (5) that compensates for the transducer
characteristics in order to generate the transmission signal sHcmp(t) corresponding to Eq. (6),
which can compensate for the FDA in the second harmonic band. The dashed line in Figure 6 is
an example of the logarithm of |RFFDA| that was measured by the simulation. From the figure
we can know that |RFFDA| is distorted at the high-frequency part and there are several small
ripple patterns, which may not be FDA characteristics and may indicate the characteristics of the
reflection process and the propagation medium. Therefore, in the actual procedure, the observed
|RFFDA| should be approximated by function fitting as a smooth function |RFFDA|*. Figure 6(a)
shows a linear approximation by line fitting of the log of |RFFDA|, and Figure 6(b) shows a
nonlinear approximation by fifth-order polynomial curve fitting. In actual use, the optimal order
of the polynomial function should be determined using appropriate criteria, but in the following
Medium Sound speed [m/s] Density [kg/m3] Attenuation coefficient [dB/cm/MHz] Nonlinear parameter [B/A]
Liver 1560–1590 1050–1070 0.75–0.95 6.75
Tumor 1900 2500 0.6 7.00
Table 2. Various parameters in simulation model mimicking the liver and tumor.
Figure 6. Logarithm of |RFFDA| measured by simulations (dashed line) and its approximations |RFFDA|* with (a) line
fitting and with (b) fifth-order polynomial function fitting (solid line).
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simulations and experiments, we compare the performance of line fitting and fifth-order poly-
nomial function fitting. Similarly, the results of RHFDA are shown in Figure 7. Comparing
Figures 6 and 7, it is obvious that the frequency dependence of FDA is larger in the second
harmonic band than in the fundamental band, which means that the distortion of the pulse
compression echo is large in the second harmonic band, and hence the influence of FDA is very
serious for harmonic imaging compared to fundamental imaging.
Figure 8(a) shows the second harmonic component of the echo from the object in Figure 5
without FDA compensation, i.e., the echo corresponds to sH(t) which compensates only the
transducer characteristics. The spectrum amplitude corresponding to Figure 8(a) is shown by
the solid line in Figure 8(b). It can be seen that the high-frequency band is greatly attenuated.
Figure 9(a) is a harmonic echo obtained by transmitting sHcmp(t) corresponding to Eq. (9) using
|RFFDA|* and |RHFDA|* approximated by line fitting. The spectrum amplitude is shown in
Figure 9(b). Figure 10 shows the results corresponding to the approximation by fifth-order
polynomial function fitting of |RFFDA|* and |RHFDA|*. From Figures 9 and 10, it is confirmed
Figure 7. Logarithm of |RHFDA| measured by simulations (dashed line) and its approximations |RHFDA|* with (a) line
fitting and with (b) fifth-order polynomial function fitting (solid line).
Figure 8. Second harmonic echo obtained by simulation without FDA compensation is shown in (a), and its spectrum
amplitude is shown in (b) as solid line with ideal amplitude as dashed line.
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that our compensation method based on amplitude-modulated transmission can effectively
avoid FDA especially for high-frequency parts. Figure 11 shows the normalized envelope
signals of compressed second harmonic echoes corresponding to Figures 9(a) and 10(a)
Figure 9. Second harmonic echo obtained by simulation with linear FDA approximation is shown in (a), and its spectrum
amplitude is shown in (b) as solid line with ideal amplitude as dashed line.
Figure 10. Second harmonic echo obtained by simulation with nonlinear FDA approximation is shown in (a), and its
spectrum amplitude is shown in (b) as solid line with ideal amplitude as dashed line.
Figure 11. Normalized envelope signal of compressed second harmonic echo obtained by simulation before FDA com-
pensation (dashed line) and after FDA compensation (solid line): (a) with linear FDA approximation and (b) with
nonlinear FDA approximation.
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respectively. The 3 dB pulse width before FDA compensation is 0.442 μs and the 3 dB pulse
width after FDA compensation is 0.378 μs with linear approximation and 0.374 μs with
nonlinear approximation. The envelope signals of the fundamental echo corresponding to the
same transmission of sHcmp(t) are shown in Figure 12. The optimal transmission for compen-
sating FDA in the fundamental band is sFcmp(t) defined in Eq. (7), but sHcmp(t) is sufficiently
effective against the fundamental FDA compensation.
4. Experiments
4.1. Experimental setup
In order to confirm the actual effectiveness of our FDA compensation, we conducted simple
experiments using the experimental system shown in Figure 13(a). The transducer used in the
experiments shown in Figure 13(b) is SONIX ISI506R having a center frequency of 5 MHz.
The amplifier is Amplifier Research 50A15, the function generator is Tektronix APG3102, and
the oscilloscope is IWATSU DS-5552. A linear FM chirp signal was transmitted toward the iron
Figure 12. Normalized envelope signal of compressed fundamental echo obtained by simulation before FDA compensa-
tion (dashed line) and after FDA compensation (solid line): (a) with linear FDA approximation and (b) with nonlinear
FDA approximation.
Figure 13. Experimental system is constructed as (a), and (b) indicates probe used in this system.
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plate placed 15 cm away from the transducer, and the echo reflected from the iron plate was
observed. The measurement conditions are shown in Table 3. Experimental verification of the
characteristics of the transducer can be realized by measurement of transmitted sound pres-
sure in water by a hydrophone. In this issue, we focused on confirming the effect of FDA
compensation and conducted experiments using frequency bands with relatively flat trans-
ducer characteristics. Hence, in the experiments, the characteristics of the transducer were not
taken into account, and only the FDA of water was compensated. That is, instead of SH(ω) in
Eq. (10), an ideal FM chirp was used to generate a signal to be transmitted.
4.2. Experimental results
In this section, the experimental results of our method for compensating FDA in the second
harmonic band caused by water corresponding to a sufficient propagating distance are shown.
Figure 14(a) shows the experimentally measured echo reflected from the iron plate without
FDA compensation. Figure 14(b) shows the second harmonic echo extracted from the whole
echo of Figure 14(a), and its spectrum amplitude is shown in Figure 14(c). In the high-frequency
part in Figure 14(c), the FDA of the second harmonic component is seen. By transmitting a
reference signal and estimating |RFFDA|* and |RHFDA|* using nonlinear polynomial function
fitting, the FDA in the second harmonic band can be compensated. Figure 15(a) shows the entire
echo with FDA compensation, and the harmonic component and its spectrum amplitude are
shown in Figure 15(b) and (c), respectively. By comparing Figures 14(c) and 15(c), the FDA
compensation at the high-frequency part can be confirmed, although the FDA is not so large
in this experiment. The reason why the FDA is smaller in the experiment than in the simulation
Type of transmission signal FM chirp with Hanning window
Center frequency [MHz] 7.5
Frequency bandwidth [MHz] 3
Pulse duration [μm] 10
Focus of transducer [mm] 15
Sampling frequency [MHz] 500
Transmission voltage [V] 40
Table 3. Measurement condition in experiments.
Figure 14. Experimentally received echo without FDA compensation: (a) whole echo, (b) harmonic echo extracted from
(a), and (c) spectrum amplitude shown as solid line (ideal amplitude is indicated as dashed line).
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is that the water attenuation is considered to be smaller than that in the living body. Therefore,
in the future study, we need to use a more attenuated propagation medium that imitates living
tissue for experiments. Figure 16 shows the normalized envelopes of the compressed echo
signals before and after FDA compensation. In addition to the second harmonic component in
Figure 16(a), the fundamental one is also shown in Figure 16(b). For both the second harmonic
component and the fundamental component, the FDA compensation is actually effective.
5. Conclusions
In this study, we proposed a novel and simple method for FDA compensation to realize the
fine THI, which can also compensate transducer characteristics. Its effectiveness was con-
firmed by two-dimensional simulations using a model imitating liver and tumor and by
simple experiments. Our method is based on FM chirp pulse compression to realize high
SNR, and we expect that fine imaging is effectively performed in a local manner by setting a
ROI determined by preimaging by conventional B-mode imaging. In this study, investigation
of FDA characteristics is assumed to be performed locally by transmitting a reference signal
Figure 15. Experimentally received echo with FDA compensation using nonlinear approximation: (a) whole echo, (b) har-
monic echo extracted from (a), and (c) spectrum amplitude shown as solid line (ideal amplitude is indicated as dashed line).
Figure 16. Experimentally obtained envelope signal of compressed echo before FDA compensation (dashed line) and
after FDA compensation (solid line): (a) second harmonic one and (b) fundamental one.
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and receiving its echo position to be finely imaged. However, it can be considered that such
FDA characteristics are invariant in the tissue region having uniform characteristics. This
indicates that it is possible to reduce the number of transmission and reception for reference
and it becomes easy to obtain the whole high-definition imaging. In the future, we will
examine such an extended method and conduct the experiments using a phantom that imitates
a living body and also the experiments on living tissue.
In the research field of ultrasound harmonic imaging, mainly the method of extracting the
harmonic component appropriately from the echo [16] and the technique to increase the noise
resistance of the harmonic component [11] are extensively examined. As sound pressure is
higher, large harmonic components are generated, so sharp transmission pulses are generally
used in many studies in general. In our study, from the viewpoint of using more energy, we
aim to improve the SNR of the harmonic components by using FM chirp pulses, and FDA
compensation is important for PCT in order to avoid deterioration of the waveform after
compression processing. We are studying a method to enable super resolution by multiple
transmission and reception with different carrier frequencies [17], and FDA compensation is
also important for applying this method to harmonic components.
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